Can Alpha Cognition’s new manufacturing process strengthen ZUNVEYL market protection?
Alpha Cognition publishes a ZUNVEYL manufacturing patent application as sales grow, targeting process protection through 2045.
Pharma & Biotech
Pharma & Biotech
Alpha Cognition expands ALPHA-1062 into traumatic brain injury, but approval is still a distant goal
Alpha Cognition won a U.S. patent for ALPHA-1062 in TBI. Read why the IP matters, what it changes, and where the biggest risks still remain.